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 Abstract 
Peganum harmala L. (Zygophylaceae) is a medicinal plant 
known to possess hypothermic and hallucinogenic 
properties from ancient times. Though the alkaloids 
identified from the species showed extensive 
pharmacological actions, they are highly cytotoxic. The 
present review summarises important findings on the 
antitumor properties and toxicity effects of the chemical 
constituents of P. harmala. 
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Peganum harmala L. (Zygophylaceae) is a perennial 
shrub growing up to 1 m tall. The seeds of P. harmala 
contain about 2–6% pharmacologically active alkaloids 
(Hilal & Young ken, 1983), which are mostly b-carbolines 
such as harman, harmine, harmaline, and harmalol 
(El-Rifaie, 1980; Kartal, Altun, & Kurucu, 2003). Seeds and 
roots contained the highest levels of alkaloids with low 
levels in stems and leaves, and absent in flowers. Harmine 
and harmaline accumulated in dry seeds at 4.3% and 5.6% 
(w/w), respectively, harmalol at 0.6%, and 
tetrahydroharmine at 0.1% (w/w). Roots contained 
harmine and harmol with 2.0% and 1.4% (w/w), 
respectively (Herraiz, González, Ancín-Azpilicueta, Arán, & 
Guillén, 2010). In traditional medicine, P. harmala has 
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been used to treat coughs, hypertension, diabetes, asthma, 
jaundice, lumbago, and many other human ailments (Riba 
et al., 2003; Tahraoui, El-Hilaly, Israili, & Lyoussi, 2007). Its 
seeds were known to possess hypothermic, and essentially 
hallucinogenic properties. Many studies have been 
conducted on the antibacterial, antifungal, antiviral and 
antitumour effects of P. harmala seeds. In Moroccan 
traditional medicine, seed powder is sometimes used on 
skin and subcutaneous tumours. 
The alkaloids identified from the plants of the genus 
Peganum showed extensive pharmacological actions, such 
as antitumor effects (Jahaniani, Ahmed Ebrahimi, 
Rahbar-Roshandel, & Mahmoudian, 2005), analgesic 
effects (Farouk, Laroubia, Aboufatimaa, Benharref, & Chait, 
2008), vasorelaxant activities (Astulla et al., 2008), 
antimicrobial activity (Prashanth & John, 1999; Arshad, 
Zitterl-Eglseer, Hasnain, & Hess,  2008), strong reversible 
inhibition of monoamine oxidase (Kim, Sablin, & Ramsay, 
1997; Schwarz, Houghton, Rose, Jenner, & Lees, 2003), and 
inhibitive activity against acetylcholinesterase (Zheng, 
Youdim, & Fridkin, 2009). In the past decades, more 
attention has been drawn on their anticancer potencies 
(Boeira, da Silva, Erdtmann, & Henriques, 2001; Go¨ckler et 
al., 2009; Adhami, Farsam, & Krenn, 2011). Recently, 
pharmacological and therapeutic effects of P. harmala and 
its main alkaloids have been reviewed (Moloudizargari, 
Mikaili, Aghajanshakeri, Asghari, & Shayegh, 2013). The 
present attempt aims to review the antitumor properties 
and toxicity effects of chemical constituents of P. harmala. 
P. harmala is a plant known since the first century A.D. 
and is still used for therapeutic purposes. Harmaline, the 
active principle of the plant seeds, and its derivatives, 
cause visual troubles, loss of coordination, agitation and 
delirium, and, at high doses, it can produce paralysis 
(Lamchouri et al., 2002). In a study designed to investigate 
some aspects of the antineoplastic properties of the P. 
harmala, varying concentrations of total alkaloid extracts 
of its seeds were tested in vitro on four tumoural cell-lines 
(Lamchouri et al., 1999). Results obtained indicate that 
alkaloids of Peganum have high cell toxicity in vitro. The 
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active principle present in the plant extract at a dose of 50 
mg/kg given orally to mice for 40 days was found to have 
significant antitumoural activity. P. harmala alkaloids thus 
possess significant antitumour potential, which could 
prove useful as a novel anticancer therapy. Subsequently, 
many studies show that the alkaloidal extract of P. harmala 
seeds is cytotoxic to several murine cell lines including 
UCP-Med and Med-mek carcinoma, and UCP-Med sarcoma 
in vitro and has an antitumor effect in a tumor model in 
vivo (Lamchouri et al., 2000; Lamchouri, 2000). Tumor 
proliferation was significantly reduced with P. harmala 
extracts (Lamchouri et al., 2000). 
In another interesting study aimed at evaluating the use 
and manipulation of therapeutic doses of aqueous extract 
of P. harmala, Wistar rats were orally dosed acutely and 
the LD50 obtained was 2.70+/-0.05g/kg (Lamchouri et al., 
2002). In chronic studies aqueous extract of P. harmala 
administered orally for six times a week at doses of 1, 1.35 
and 2g/kg during 3 month period increased 
transaminases. Changes in glucose and creatinine were not 
significant. No significant gross changes were found at 
necropsy. Histologic study showed liver degeneration and 
spongiform changes in the central nervous system (CNS) in 
rats treated with 2g/kg dose but not at the therapeutic 
dose of 1g/kg. 
The β-carboline alkaloids present in medicinal plants 
like P. harmala have recently drawn attention due to their 
antitumor properties. Recently, in an attempt to discover 
novel b-carboline alkaloids with potent antitumor activity 
and low neurotoxicity, nine harmine derivatives were 
investigated for their antitumor effects and acute toxicities 
in mice, and structure–activity relationship (SAR) analysis 
(Rihui et al., 2004 ; Qi et al., 2004). In their study, nine 
harmine derivatives (including harmine) were 
investigated for their potential cytotoxicities against 
human HepG2 cells using 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) assays. The harmine 
and its derivatives resulted in in vitro cytotoxicity (IC50) 
values of 0.011–0.021 lmol/ml HepG2 cells.  
To recognize the structure–activity relationships, the 
molecular structures of the series of nine harmine 
derivatives (including harmine) have been studied. The 
tumor inhibition rates of harmine derivatives in mice 
bearing Lewis lung cancer, sarcoma180, or HepA tumor 
shows that harmine has only moderate antitumor effect, 
yet some of the derivatives showed inhibition rates of 
more than 40% while few others exhibited the highest 
antitumor effect among these compounds. It appears that 
both short alkyl and aryl substitution at R9 is favourable 
for antitumor activity, but aryl substitution is more 
favourable. The SAR analysis indicated that the formate 
substitution at R3 of the tricyclic skeleton reduced their 
neurotoxicity, while the short alkyl or aryl substitution at 
R9 increased the antitumor activity. All these findings 
indicate that compounds with both substitutions at R3 and 
R9 have high antitumor activity and low toxicity (Qi et al., 
2004). 
The antiproliferative activity of four alkaloids 
harmalacidine, harmine, peganine, and vasicinone isolated 
from P. harmala seeds and theirs computational study was 
investigated by Lamchouri, Toufik, Bouzzine, Hamidi, & 
Bouachrine (2010). These compounds were assayed in 
vitro for their effect on thymidine incorporation using 
Jurkat leukemia cell line at concentration of 5, 10, 25, 50, 
and 100 lg/ml. Their cytotoxicity was also evaluated at the 
concentrations indicated above on Sp2/O-Ag14 myeloma 
cells, Med-mek carcinoma, UCP-med Carcinoma, and 
UCP-med sarcoma. Results showed that vasicinone, 
harmine, and harmalacidine inhibited the proliferation of 
Jurkat, clone E6-1 cell line with significant cytotoxic effect. 
No noticeable effect of peganine on thymidine 
incorporation was observed. These in vitro studies have 
shown that harmine, b-carbolines alkaloid have more 
activity (Lamchouri et al., 2010). The harmine and 
β-carbolines alkaloid are highly cytotoxic and significantly 
inhibited tumor cell growth with apoptotic effect (Hamsa 
& Kuttan, 2011). This study showed that harmine 
significantly inhibited tumor nodule formation in the lung 
tissue and decreased various biochemical parameters 
associated with lung metastasis. 
In order to identify the components in the seed extract 
of P. harmala responsible for the cytotoxic effects, four 
alkaloids: harmalicidine, harmine, peganine (vasicine) and 
vasicinone were isolated (Lamchouri et al., 2013). The 
study also focused on the cytotoxic and antiproliferative 
activity of the isolated alkaloids and total alkaloidal 
fraction (TAF) in several tumor cell lines. The alkaloids 
and TAF inhibited the growth of tumor cell lines to varying 
degrees. Of the substances evaluated, harmine was the 
most active compound (IC50 for the 4 tumor cell lines 
varying between 2.43 µg/ml and 18.39 µg/mL), followed 
by TAF (range of IC50 = 7.32 µg/mL to 13.83 µg/mL); 
peganine was the least active (IC50 = 50 µg/mL to > 100 
µg/ml). In terms of antiproliferative effect, vasicinone and 
TAF were more potent than other substances: the 
concentration of vasicinone, and TAF needed to inhibit the 
incorporation of {3H-TDR} in the DNA cells of Jurkat, E6-1 
clone by 50% (IC50) were 8.60 ± 0.023 µg/mL and 8.94 ± 
0.017 µg/mL, respectively, while peganine was the least 
active (IC50 >100 µg/mL). The IC50 values for 
harmalacidine (27.10 ± 0.011 µg/mL) and harmine (46.57 
± 0.011 µg/mL) were intermediate. The harmala alkaloids 
inhibited the growth of four tumor cell lines, and 
proliferation of Jurkat cells with varying potencies. 
Harmine was the most potent in inhibiting cell growth, and 
vasicinone was most active as antiproliferating substance. 
The TAF had significant cytotoxic as well as 
antiproliferating activity.  
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It is well known that alkaloids from P. harmala inhibited 
the growth of tumor cell lines but a study conducted in 
China revealed that total alkaloids from seeds of P. 
harmala possessed significant growth inhibitory effect on 
plants (Shao, Huang, Zhang, & Zhang, 2013). Harmaline 
exerted potent inhibitory effects on seedling growth of 
treated plants, especially dicots, inhibiting root elongation 
of lettuce and amaranth by 31% and 47% at a very low 
concentration (5 µg/mL), whereas harmine exhibited 
much weaker non-selective inhibitory effect on the plants. 
Considering the high yield and poor utilization of P. 
harmala in China, it is anticipated that this plant could be 
exploited as an alternative weed management tool in the 
future. In another study, the leaf extract and its fractions of 
P. harmala have shown pronounced mortal effect, 
decreased percent pupation and adult emergence of the 
cotton leaf worm, Spodoptera littoralis Boisd (Shonouda, 
Osman, Salama, & Ayoub, 2008). The medicinal plant P. 
harmala could be carefully applied in integrated pest 
management due to its strong effect on cotton leaf worm 
pest. Interestingly, a novel protein extracted from P. 
harmala inhibited growth of fungi such as Alternaria 
alternate, Penicillium degitatum, Rhizopus stuolonifer, and 
Magnaporthe grisea, and its antifungal activity was stable 
in the temperature range 4-60°C, and in the pH range 4-10 
(Ma et al., 2013).  
In a recent study (Daoud, Song, Xiao, & Shang, 2014), 
B-9-3, a semi-synthetic derivative of ß-carboline that is 
formed of two harmane molecules bound by a butyl group, 
exhibited anti-proliferative effect against a human lung 
cancer cell line, a human breast cancer cell line, and a 
human colorectal carcinoma cell line via induction of 
apoptosis and inhibition of cell migration. Moreover, B-9-3 
inhibited tube formation in human umbilical vascular 
endothelial cell line (HUVEC), which indicates an 
anti-angiogenesis activity in vitro. Earlier molecular 
docking studies (Misra et al., 2008) suggest that a binding 
interaction with DNA topoisomerase I of Leishmania 
donovani (binding energy of -79 kcal/mol) forms a stable 
complex, indicating a possible role in apoptosis. 
In conclusion, alkaloids from P. harmala show strong 
antitumor properties and in the mean time exhibited acute 
toxicity. Hence, one must be careful while using the seed 
extracts for traditional medicinal preparations and for any 
drug development programmes. In the mean time, it is to 
be noted that there is evidence for anti oxidative efficacy of 
P. harmala (Soliman, Abu-El-Zahab, & Alswiai, 2013; Khlifi 
et al., 2013). Analysis of purified protein from seeds of P. 
harmala plant against carbon tetrachloride (CCl4) induced 
oxidative stress in rats showed strong antioxidant activity 
(Soliman et al., 2013). Further, considering the increased 
rate of environmental pollution, contaminants such as 
dioxins are very prevalent on the environment that have 
been linked with a variety of deleterious effects on human 
health including increased cancer rates. Studies proved 
that P. harmala is a candidate herbal plant for preventing 
dioxin mediated effects (El Gendy, Somayaji, & El-Kadi, 
2010).  
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